Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

4,793 total articles

Cerus: Q1 Follow-Through Makes a Convincing Case to Buy the Turnaround

Cerus: Q1 Follow-Through Makes a Convincing Case to Buy the Turnaround

Cerus (CERS) looks like a validated turnaround after recent results and follow-through in price and volume. The company still carries execution risk and a stretched valuation relative to profitability, but the combination of rising demand for INTERCEPT systems, a cleaner cash runway and a surge in short interest sets up a trade with asymmetric upsi…

Verizon Remains a Buy After Q1: Income, FCF, and 5G Momentum Intact

Verizon Remains a Buy After Q1: Income, FCF, and 5G Momentum Intact

Verizon is trading near $47 with a 5.9% yield, healthy free cash flow of $20.3B, and improving subscriber and EBITDA momentum. The stock looks attractively valued at ~11x earnings and ~7.5x EV/EBITDA. For income-focused traders who also want upside, a mid-term swing trade into $52.50 with a $44 stop provides a favorable risk/reward while preserving…

Buy Eli Lilly After Q1 Strength — Momentum Meets Durable Cash Flow

Buy Eli Lilly After Q1 Strength — Momentum Meets Durable Cash Flow

Eli Lilly reported explosive top-line and EPS growth driven by its GLP-1 franchise and pipeline momentum. With rumored incremental 2026 revenue upside, a clean safety profile on key non-GLP assets and free cash flow of roughly $11.8B, LLY looks set for further appreciation. This trade idea lays out a clear entry, stop and target across a position-l…

KRYS: Look Past VYJUVEK - The Pipeline Is the Real Growth Engine

KRYS: Look Past VYJUVEK - The Pipeline Is the Real Growth Engine

Krystal Biotech's marketed product VYJUVEK has put the company on the map and produced strong revenue in 2025, but investors are underpricing the optionality from multiple gene-therapy programs with near-term catalysts. With solid cash on the balance sheet, positive free cash flow, and a suite of presentations and readouts ahead, KRYS is a buy for …

Buying Dell Near the Top Feels Risky - Still Putting a Sliver to Work

Buying Dell Near the Top Feels Risky - Still Putting a Sliver to Work

Dell is trading near its 52-week high after a big gap higher, driven by AI supercomputer deals and improving ISG dynamics. Valuation is full by several measures and momentum is stretched, but cash generation ($8.55B FCF) and meaningful enterprise exposure make a scaled, risk-defined long sensible for a swing trade. Entry $255, stop $235, target $30…

Nutrien: Underpriced Exposure to a Structural Fertilizer Shortage

Nutrien: Underpriced Exposure to a Structural Fertilizer Shortage

Nutrien (NTR) is a high-quality crop nutrient platform trading at a modest P/E and a 3.2% yield while sitting squarely in the path of a global fertilizer supply squeeze. The market is discounting Fertilizer cyclicality more than the durable demand drivers, creating an asymmetric trade - income today and meaningful upside if supply dynamics persist.

MongoDB Setup: Atlas Momentum + AI Demand = Tactical Long Into Earnings

MongoDB Setup: Atlas Momentum + AI Demand = Tactical Long Into Earnings

MongoDB's Atlas product and growing AI workloads keep the growth narrative intact despite recent volatility. Technical momentum, improving free cash flow ($500M), and a valuation that prices future growth create a tactical long setup into upcoming catalysts. Trade plan with entry at $300, stop at $275, target $380 for a mid-term (45 trading days) h…

CrowdStrike: Pay Up For Growth - Upgrade to Buy

CrowdStrike: Pay Up For Growth - Upgrade to Buy

CrowdStrike's platform momentum, expanding AI security roadmap, and accelerating ARR justify holding a premium valuation. We upgrade to Buy and lay out an actionable entry at $528, stop at $480 and a target of $640 over a 180 trading-day horizon. Risks include macro sensitivity, execution on AI integrations, and a richly priced multiple.

PDD: Buy the Cash Compounder That the Market Is Misreading

PDD: Buy the Cash Compounder That the Market Is Misreading

PDD Holdings is trading like a broken e-commerce story while generating industry-scale cash flow and investing to protect long-term optionality. I view the current price as an opportunity to pick up a high-cash, low-valuation compounder. This trade is a long with a clear entry, stop and target tied to the company’s balance-sheet strength and potent…

Fastly: Betting the Edge Cloud Re-rate after the Q1 Shock

Fastly: Betting the Edge Cloud Re-rate after the Q1 Shock

Fastly's core networking growth disappointed, but Security and Compute are expanding rapidly and management raised 2026 guidance. The stock sold off sharply, creating a tactical long setup that captures an underpriced edge-cloud inflection. Trade plan given for a mid-term (45 trading days) horizon with clear entry, stop and target.

From Copper King to Photonics Powerhouse: A Trade Idea on Credo (CRDO)

From Copper King to Photonics Powerhouse: A Trade Idea on Credo (CRDO)

Credo is executing a fast pivot from high-performance copper SerDes and active electrical cables into silicon photonics after the DustPhotonics deal. Management is guiding toward meaningful optical revenue and accretive EPS, and the stock still shows momentum despite elevated multiples. This trade idea lays out a long entry, targets, stop, catalyst…

Palantir's Pullback Masks a Business Re-rating Opportunity

Palantir's Pullback Masks a Business Re-rating Opportunity

Palantir reported blowout Q1 results and raised guidance, but the stock has retraced sharply from its 52-week highs. Fundamentals show accelerating revenue (about 84-85% y/y), expanding profit and meaningful free cash flow, while valuation metrics remain extreme. This trade idea targets a re-rating scenario: buy a measured pullback with a clear sto…

Why Meta’s Pullback Is a Tactical Buying Opportunity

Why Meta’s Pullback Is a Tactical Buying Opportunity

Meta’s shares have pulled back into the low $600s after a recent stretch of sector volatility. Fundamentals are solid - $48.3B free cash flow, a 22x P/E and 29% ROE - and technicals show a constructive support band near $600. This trade idea lays out an entry at $610, a stop at $560 and a $750 target over a 46-180 trading day horizon, with clear ca…

GTN Set To Rebound: Buy the Dip on an Oversold Local-TV Play

GTN Set To Rebound: Buy the Dip on an Oversold Local-TV Play

Gray Media (GTN) is trading well below its short-term technical averages amid heavy volume and elevated short interest. The combination of a healthy free cash flow print, an attractive 7%+ dividend, recent carriage and acquisition-related catalysts, and deep valuation multiples make a dip-buy trade compelling for a mid-term swing. Risk is real - le…